The biotech industry includes bio-pharma, bio-services, bio-agri, bio-industrials and bioinformatics. Biopharma is a rapidly growing segment that accounts for a dominant share in this sector. Advancements in biotechnology have enabled researchers to evaluate and identify target biomarkers/cell receptors to develop targeted and personalized therapies. Scientific research and technological advancements have resulted in the emergence of various personalized medicines that are undergoing research. According to research conducted by the Personalized Medicine Coalition, 42% of all compounds and 73% of oncology compounds in the pipeline possess the potential to be personalized medicine. Moreover, according to this study, it is expected that companies will increase their investment in R&D of personalized medicines by 1/3rd over the following five years. The study found that over 20% of drugs approved in 2014 were personalized medicines.

The biotechnology sector has witnessed some disruptive innovations such as gene and cell therapies, immunotherapy, and antibody drug conjugates. Advancement in stem cell therapy is resulting in effective treatment therapies for chronic conditions, organ growth and repair and disease prevention.

Key Challenges

Biotech products have extensive application in oncology and autoimmune disease treatment. However, the cost of these drugs is high owing to extensive research and trials that need to be carried out for the same. Therefore, there is constant pressure to reduce price and increase accessibility, especially in emerging economies. In the U.S., companies are facing reimbursement issues with respect to biopharmaceutical products. Besides, there are regulatory and scientific challenges faced by the sector. Scientific research for new molecules and targeted therapies is capital intensive and challenging owing to growing concern for safety of the drug.

Also, there is lack of awareness about personalized medicine among most healthcare providers, which may hamper its adoption. Clinical adoption of biotechnology products is essential for its success. However, it significant scientific evidence and backing is required to ensure its safety.

“Translating genomic discoveries into personalized medicines entails overcoming substantial scientific, regulatory, and economic challenges, including identifying validated biomarkers, as well as developing personalized therapeutics and clinically relevant diagnostic tests.”

Tufts Center for the Study of Drug Development

Opportunities

The biopharmaceutical sector offers vast lucrative growth opportunities. High efficacy and safety of biopharmaceutical products has led to a growth in their demand, Furthermore, consumers are willing to pay high prices for biopharmaceutical products compared to other conventional products. Biopharmaceutical brands have set new standards for blockbuster drugs by recording an annual average sale of over US$ 2bn. Drugs such as Humira have generated sales revenue of over US$ 10bn.

Governments in emerging economies are endorsing biosimilars as cost-effective alternatives to biotech products, which is expected to create significant growth opportunities for manufacturers of generic drugs. Therefore, cost-effectiveness and high quality are prime parameters that need to be considered while developing biosimilars. Recent and upcoming biologic patent expirations include the following:

Erbitux (cetuximab) - February 2016
Rituxan (rituximab) - September 2016
Herceptin (trastuzumab) - June 2019
Avastin (bevacizumab) - July 2019
Aranesp (darbepoetin alfa) - May 2024
Enbrel (etanercept) - November 2028

Companies such as Teva Pharmaceuticals, Hospira, Sandoz, and Amgen are focusing on development of biosimilars and vaccines as preventive measures in addition to treatment. For instance, in 2015, Zarxio TM became the first biosimilar to be approved in the U.S. market. The EMA approved Mosquirix, a malaria vaccine, in the same year. Extensive research is currently underway to develop a dengue vaccine, which could be another breakthrough pharmaceutical product in the near future.

Conclusion

The increasing research in the biotechnology sector is expected to result in higher number of biopharmaceutical products seeking FDA approvals. Biopharmaceuticals are positioned to be promising treatment solutions that would improve patient outcomes and help with reduction of the cost of drug development.View less

Specialty and Fine Chemicals

Cosmetic Ingredients

Food Ingredients

Aerospace and Defense

Automotive and Transportation

Consumer Electronics

Construction Engineering

Industrial Automation and Machinery

Semiconductors

Smart Technologies

Information and Communication Technology

Biotechnology Published Insights

Metagenomics Market

Published Date : Feb 2025

Global metagenomics market is estimated to be valued at USD 2.36 Bn in 2025 and is expected to exhibit a CAGR of 8.3% during the forecast period (2025-2032). Metagenomics is the study of genetic material recovered directly from environmental samples without cultivat... View more

Cell Free Protein Expression Market

Published Date : Feb 2025

Global cell-free protein expression market is estimated to be valued at USD 341.4 Mn in 2025 and is expected to exhibit a CAGR of 7.3% during the forecast period (2025-2032). Cell-free protein expression, also known as in vitro protein synthesis, is a biotechnologic... View more

Biomarker Research Services Market

Published Date : Feb 2025

Global biomarker research services market is estimated to be valued at USD 10.98 Billion in 2025 and is expected to reach USD 310.66 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 61% from 2025 to 2032. The global biomarker research services m... View more

Bio Pharmaceuticals And Biomedicine Market

Published Date : Feb 2025

The Global Biopharmaceutical and Biomedicine Market is estimated to be valued at USD 640.26 Bn in 2025 and is expected to reach USD 1,425.17 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.91% fr... View more

Gene Editing Market

Published Date : Feb 2025

The Global Gene Editing Market is estimated to be valued at USD 4.80 Bn in 2025 and is expected to reach USD 9.51 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 10.2% from 2025 to 2032. Gene editing is... View more

Dogs Vaccines Market

Published Date : Feb 2025

The Global Dogs Vaccines Market is estimated to be valued at USD 2.21 Billion in 2025 and is expected to reach USD 3.52 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032. Growi... View more

Exosomes Market

Published Date : Jan 2025

The Global Exosomes Market is estimated to be valued at USD 222.1 Mn in 2025 and is expected to reach USD 1,284.1 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 28.5% from 2025 to 2032. Exosomes are na... View more

Human Primary Cell Culture Market

Published Date : Jan 2025

The Global Human Primary Cell Culture Market is estimated to be valued at USD 4.10 Bn in 2025 and is expected to reach USD 8.61 Bn by 2032 exhibiting a compound annual growth rate (CAGR) of 11.2% from 2025 to 2032. Hu... View more

Spatial Proteomics Market

Published Date : Jan 2025

The Global Spatial Proteomics Market is estimated to be valued at USD 87.5 Mn in 2025 and is expected to reach USD 153.8 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.4% from 2025 to 2032. Spatial p... View more

Cell Separation Market

Published Date : Jan 2025

The Global Cell Separation Market is estimated to be valued at USD 9.90 billion in 2025 and is expected to reach USD 19.11 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.8% from 2025 to 2032. Ce... View more

Spatial Omics Market

Published Date : Mar 2024

Spatial omics technologies have emerged during the last few years and have changed the way we understand multicellular biological systems, which includes genomics, transcriptomics, proteomics, and metabolomics. Conventional proteom... View more

Crispr Technology Market

Published Date : Mar 2024

CRISPR technology is driving advances in genome editing across medicine, pharmaceutical, biotechnology, and agriculture, which has enabled scientists to conduct research in these fields through faster and more efficient genome editing across the world. CRISPR is also ... View more

Swine Fever Vaccine Market

Published Date : Mar 2024

There are two types of swine fever – Classical Swine Fever (CSF) and African Swine Fever (ASF). Classical swine fever (CSF) is an extremely contagious viral disease in pigs. The severity of the disease varies with the strain of the virus, the immune status of th... View more

Cell Expansion Market

Published Date : Mar 2024

Cell expansion is the production of daughter cells from a single cell. Cell expansion requires the creation of new cell wall material and organized releasing of the wall to allow it to stretch and increase in area. Cell-wall-associated proteins are key components in c... View more

Ipv Vaccines Market

Published Date : Mar 2024

Inactivated polio vaccine (IPV) is also known as Salk vaccine. For the vaccination against polio there are two vaccines available: inactivated polio vaccine and oral polio vaccine. The IPV vaccine is mostly given in arm or leg as a shot. ... View more

Global Cholera Vaccines Market

Published Date : Feb 2024

Cholera is a bacterial disease that usually spreads through contaminated water. It causes severe diarrhea and dehydration and can be fatal within hours if left untreated. The disease is most prevalent in areas with inadequate water treatment, poor sanitation, and inad... View more

Global Multiomics Market

Published Date : Feb 2024

Multiomics refers to the integrated omics approach that combines diverse omic technologies such as genomics, epigenomics, transcriptomics, proteomics, and metabolomics to obtain comprehensive insights into biological systems. By integrating multiple layers of biologic... View more

Global Induced Pluripotent Stem Cells Market

Published Date : Feb 2024

Induced pluripotent stem cells (iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The discovery of induced pluripotent stem cells revolutionized the field of regenerative medicine as it provided an ethically superior alternati... View more